- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 NAG.10: 2 residues within 4Å:- Chain A: Y.28, N.61
 
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.122, T.124, N.125
 
Ligand excluded by PLIPNAG.12: 2 residues within 4Å:- Chain A: E.132, N.165
 
Ligand excluded by PLIPNAG.13: 3 residues within 4Å:- Chain A: G.232, I.233, N.234
 
Ligand excluded by PLIPNAG.14: 2 residues within 4Å:- Chain A: N.331, Q.580
 
Ligand excluded by PLIPNAG.15: 2 residues within 4Å:- Chain A: E.309, N.603
 
Ligand excluded by PLIPNAG.16: 1 residues within 4Å:- Chain A: N.616
 
Ligand excluded by PLIPNAG.17: 2 residues within 4Å:- Chain A: H.655, N.657
 
Ligand excluded by PLIPNAG.18: 2 residues within 4Å:- Chain A: N.706, G.1128
 
Ligand excluded by PLIPNAG.19: 1 residues within 4Å:- Chain A: N.1071
 
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain A: N.1095, T.1097, F.1100
 
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain A: N.1131
 
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: G.339, F.342, N.343, F.374
 
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain A: N.280, E.281, N.282
 - Chain B: K.558
 
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain B: Y.28, N.61
 
Ligand excluded by PLIPNAG.25: 2 residues within 4Å:- Chain B: N.616, T.618
 
Ligand excluded by PLIPNAG.26: 2 residues within 4Å:- Chain B: N.706, G.1128
 
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain B: N.1071
 
Ligand excluded by PLIPNAG.28: 1 residues within 4Å:- Chain B: N.1131
 
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: G.339, F.342, N.343
 
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: N.280, E.281, N.282
 
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain C: Y.28, N.61
 
Ligand excluded by PLIPNAG.32: 1 residues within 4Å:- Chain C: N.603
 
Ligand excluded by PLIPNAG.33: 2 residues within 4Å:- Chain C: N.616, T.618
 
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain C: H.655, N.657
 
Ligand excluded by PLIPNAG.35: 1 residues within 4Å:- Chain C: N.706
 
Ligand excluded by PLIPNAG.36: 1 residues within 4Å:- Chain C: N.1071
 
Ligand excluded by PLIPNAG.37: 1 residues within 4Å:- Chain C: N.1131
 
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: G.339, F.342, N.343
 
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain C: N.280, N.282
 
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain C: Q.115, N.165
 
Ligand excluded by PLIP- Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Fan, C. et al., Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles. Proc.Natl.Acad.Sci.USA (2025)
          


 - Release Date
 - 2025-06-04
 - Peptides
 - Spike glycoprotein: ABC
M8b-B8 heavy chain: DF
M8b-B8 light chain: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
ME
LG
N 
- Coordinates
 - PDB Format
 - Method
 - ELECTRON MICROSCOPY
 - Oligo State
 - hetero-3-2-2-mer
 - Ligands
 - 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - 31 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
 - Links
 - RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
 - Citation
 - Fan, C. et al., Cross-reactive sarbecovirus antibodies induced by mosaic RBD nanoparticles. Proc.Natl.Acad.Sci.USA (2025)
          


 - Release Date
 - 2025-06-04
 - Peptides
 - Spike glycoprotein: ABC
M8b-B8 heavy chain: DF
M8b-B8 light chain: EG - SMTL:PDB
 - SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
HF
ME
LG
N